Evaluation of isotretinoin effects on depression, sleep apnea and sleep quality.
Cutan Ocul Toxicol
; 43(2): 129-133, 2024 Jun.
Article
em En
| MEDLINE
| ID: mdl-38608451
ABSTRACT
BACKGROUND:
Isotretinoin is used to treat severe acne, treatment-resistant moderate acne, and acne that leads to scarring or psychological distress. It has many side effects and is also associated with depression, sleep apnea, and sleep disturbances.OBJECTIVES:
In this study, we aimed to evaluate the effects of isotretinoin on depression, sleep apnea, and sleep quality.METHODS:
A total of 42 patients diagnosed with acne and started isotretinoin treatment were included in the study. In order to compare the effects of isotretinoin, patients were asked to fill out a questionnaire containing the Beck Depression Inventory (BDI), the Berlin Questionnaire (BQ), and the Pittsburg Sleep Quality Index (PSQI) at baseline and third months of treatment.RESULTS:
There was no statistically significant difference in BDI, BQ, and PSQI scores between the 1st and 3rd months of treatment (p = .53, p = .5, p = .35).CONCLUSION:
This study showed that isotretinoin had no significant effects on depression and sleep quality.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Síndromes da Apneia do Sono
/
Isotretinoína
/
Acne Vulgar
/
Depressão
/
Fármacos Dermatológicos
/
Qualidade do Sono
Limite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Cutan Ocul Toxicol
/
Cutan. ocul. toxicol
/
Cutaneous and ocular toxicology
Assunto da revista:
DERMATOLOGIA
/
OFTALMOLOGIA
/
TOXICOLOGIA
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Turquia